|
BARD ACCESS SYSTEMS SMALL TITANIUM HICKMAN P; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
|
Back to Search Results |
|
| Model Number |
0602180 |
| Medical Device Problem Codes |
Fluid/Blood Leak (1250); Appropriate Device Problem Term/Code Not Available (3191)
|
| Health Effect - Clinical Codes |
Extravasation (1842); Pain (1994); Swelling (2091)
|
| Date of Event |
07/20/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiration date: 08/2018).
|
| |
|
Event or Problem Description
|
|
It was reported that approximately five years post placement of the port catheter via the right facial vein, during home infusion of saline, benefix and heparin the port was allegedly leaking externally.Reportedly, the health care provider administered tissue plasminogen activator (tpa).It was further reported that while performing the dye study, the patient experienced pain and swelling at the port site as the contrast medium leaked through the silicone septum of the port.It was further reported that the device was removed and replaced on the same day.The patient was reportedly stable after the removal and replacement of the device.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately five years post placement of the port catheter via the right facial vein, during home infusion of saline, benefix and heparin the port was allegedly leaking externally.Reportedly, the health care provider administered tissue plasminogen activator (tpa).It was further reported that while performing the dye study, the patient experienced pain and swelling at the port site as the contrast medium leaked through the silicone septum of the port.It was further reported that the device was removed and replaced on the same day.The patient was reportedly stable after the removal and replacement of the device.
|
| |
|
Additional Manufacturer Narrative
|
|
Manufacturer review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Images and medical records were not provided for review.Therefore, the investigation is inconclusive for the alleged leaking port as no objective evidence has been provided to confirm any alleged deficiency with the port.The root cause could not be determined based upon available information.It is unknown whether patient and/or procedural factors contributed to the event.The investigation for the leaking port is inconclusive.Labeling review: a review of product labeling documents (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.H10: d4 (expiration date: 08/2018), g4.H11: g1, h6 (device code).
|
| |
|
Search Alerts/Recalls
|
|
|